Re: Comparison of immediate vs. deferred cytoreductive nephrectomy in patients with synchronous metastatic renal cell carcinoma receiving sunitinib: the SURTIME randomized clinical trial

被引：1
|
作者：
Minervini, Andrea [1 ]
Mari, Andrea [1 ]
Di Maida, Fabrizio [1 ]
Campi, Riccardo [1 ]
Carini, Marco [1 ]
Lapini, Alberto [1 ]
机构：
[1] Univ Florence, Careggi Hosp, Unit Oncol Minimally Invas Urol & Androl, Dept Urol, Florence, Italy
来源：
TRANSLATIONAL CANCER RESEARCH | 2019年 / 8卷
关键词：
INTERFERON-ALPHA; MONOTHERAPY; CANCER;
D O I：
10.21037/tcr.2019.03.08
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
[No abstract available]
引用
收藏
页码：S208 / S210
页数：3
相关论文
共 50 条
  • [21] Cytoreductive Nephrectomy for Synchronous Metastatic Renal Cell Carcinoma-Are There Any Favorable Risk Patients?
    Patel, Hiten D.
    Clark, Joseph I.
    Flanigan, Robert C.
    JOURNAL OF UROLOGY, 2021, 206 (01): : 4 - 6
  • [22] Therapeutic role of deferred cytoreductive nephrectomy in patients with metastatic renal cell carcinoma treated with nivolumab plus ipilimumab
    Yoshino, Maki
    Ishihara, Hiroki
    Nemoto, Yuki
    Nakamura, Kazutaka
    Nishimura, Koichi
    Tachibana, Hidekazu
    Fukuda, Hironori
    Toki, Daisuke
    Yoshida, Kazuhiko
    Kobayashi, Hirohito
    Iizuka, Junpei
    Shimmura, Hiroaki
    Hashimoto, Yasunobu
    Tanabe, Kazunari
    Kondo, Tsunenori
    Takagi, Toshio
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2022, 52 (10) : 1208 - 1214
  • [23] Considerations for the Next Clinical Trial Evaluating the Role of Cytoreductive Nephrectomy for Metastatic Renal Cell Carcinoma
    Kim, Hyung L.
    Mayerson, Eddie
    Lara, Primo N.
    Messing, Edward
    Tangen, Cathy
    Shuch, Brian M.
    Vaishampayan, Ulka
    EUROPEAN UROLOGY FOCUS, 2019, 5 (06): : 927 - 929
  • [24] Differences in Survival of Clear Cell Metastatic Renal Cell Carcinoma According to Partial vs. Radical Cytoreductive Nephrectomy
    Garcia, Cristina Cano
    Flammia, Rocco S.
    Piccinelli, Mattia
    Panunzio, Andrea
    Tappero, Stefano
    Barletta, Francesco
    Incesu, Reha-Baris
    Law, Kyle W.
    Morra, Simone
    Tian, Zhe
    Saad, Fred
    Kapoor, Anil
    Shariat, Shahrokh F.
    Longo, Nicola
    Tilki, Derya
    Briganti, Alberto
    Terrone, Carlo
    Antonelli, Alessandro
    De Cobelli, Ottavio
    Hoeh, Benedikt
    Kluth, Luis A.
    Chun, Felix K. H.
    Karakiewicz, Pierre I.
    CLINICAL GENITOURINARY CANCER, 2024, 22 (01) : 1 - 6
  • [25] The role of cytoreductive nephrectomy in patients with synchronous metastatic renal cell carcinoma and prognostic factors for overall survival
    Low, W. X. A.
    Gu, T.
    Yuen, S. P. J.
    Lee, L. S.
    Toh, C. K.
    Kanesvaran, R.
    Tan, H. S.
    Huang, H. H.
    Lau, K. O. W.
    BJU INTERNATIONAL, 2015, 115 : 93 - 94
  • [26] The role of cytoreductive nephrectomy in patients with synchronous metastatic renal cell carcinoma and prognostic factors for overall survival
    Low, W. X. A.
    Gu, T.
    Lim, K. S. J.
    Yuen, S. P. J.
    Lee, L. S.
    Toh, C. K.
    Kanesvaran, R.
    Tan, H. S.
    Huang, H. H.
    Lau, K. O. W.
    BJU INTERNATIONAL, 2015, 115 : 8 - 8
  • [27] The role of cytoreductive nephrectomy in patients with synchronous metastatic renal cell carcinoma and prognostic factors of overall survival
    Alvin, Low Wei Xiang
    BJU INTERNATIONAL, 2016, 118 : 28 - 28
  • [28] TARIBO trial: Cytoreductive nephrectomy in metastatic renal cell carcinoma patients treated with targeted agents
    Grassi, Paolo
    Verzoni, Elena
    Bearz, Alessandra
    Bracarda, Sergio
    Bregni, Marco
    Buti, Sebastiano
    Cinieri, Saverio
    De Giorgi, Ugo
    Fornarini, Giuseppe
    Galli, Luca
    Milella, Michele
    Morelli, Franco
    Nole, Franco
    Passalacqua, Rodolfo
    Sabbatini, Roberto
    Santini, Daniele
    Salvioni, Roberto
    Cappelletti, Vera
    Ratta, Raffaele
    Procopio, Giuseppe
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [29] Final clinical results of a randomized phase II international trial of everolimus vs. sunitinib in patients with metastatic non-clear cell renal cell carcinoma (ASPEN)
    Armstrong, Andrew J.
    Broderick, Samuel
    Eisen, Tim
    Stadler, Walter Michael
    Jones, Robert J.
    Garcia, Jorge A.
    Vaishampayan, Ulka N.
    Picus, Joel
    Hawkins, Robert E.
    Hainsworth, John D.
    Kollmannsberger, Christian K.
    Logan, Theodore F.
    Puzanov, Igor
    Pickering, Lisa M.
    Ryan, Christopher W.
    Protheroe, Andrew
    Lusk, Christine M.
    Oberg, Sadie
    Halabi, Susan
    George, Daniel J.
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [30] Pathological Response and Outcomes in Patients With Metastatic Renal Cell Carcinoma (mRCC) Receiving Immunotherapy-Based Therapies and Undergoing Deferred Cytoreductive Nephrectomy (CN)
    Gunenc, Damla
    Issa, Wadih
    Gerald, Thomas
    Zhou, Qinhan
    Zhang, Song
    Ibezue, I. Chidera
    Bhanvadia, Raj
    Tachibana, Isamu
    Brugarolas, James
    Hammers, Hans
    Qin, Qian
    Kapur, Payal
    Woldu, Solomon
    Gaston, Kris
    Lotan, Yair
    Cadeddu, Jeffrey
    Wang, Andrew Z.
    Margulis, Vitaly
    Zhang, Tian
    CLINICAL GENITOURINARY CANCER, 2024, 22 (05)
12345